Currently, the recommended screening method for NAFLD in children includes elevated alanine aminotransferase (ALT) serum concentration, concurrent with obesity and other risk factors for metabolic disease, such as a family history of diabetes [2]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.